News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

20,858 Results

Type

Article (1739)
Company Profile (19)
Press Release (19100)

Section

Business (7086)
Career Advice (22)
Deals (1034)
Drug Delivery (3)
Drug Development (3683)
Employer Resources (3)
FDA (339)
Job Trends (396)
News (11362)
Policy (707)

Tag

Date

Today (9)
Last 7 days (20)
Last 30 days (78)
Last 365 days (1468)
2025 (75)
2024 (1467)
2023 (1760)
2022 (2381)
2021 (2405)
2020 (1939)
2019 (1255)
2018 (886)
2017 (1098)
2016 (941)
2015 (1119)
2014 (796)
2013 (659)
2012 (605)
2011 (622)
2010 (529)

Location

Africa (27)
Asia (1303)
Australia (144)
California (214)
Canada (57)
China (16)
Connecticut (9)
Delaware (4)
Europe (5472)
Florida (23)
Illinois (5)
Maryland (75)
Massachusetts (113)
Minnesota (7)
New Jersey (43)
New York (21)
North Carolina (18)
Northern California (79)
Ohio (4)
Pennsylvania (65)
South America (24)
Southern California (79)
Texas (18)
Utah (7)
Washington State (12)

Filters

Type

Article (1739)
Company Profile (19)
Press Release (19100)

Section

Business (7086)
Career Advice (22)
Deals (1034)
Drug Delivery (3)
Drug Development (3683)
Employer Resources (3)
FDA (339)
Job Trends (396)
News (11362)
Policy (707)

Tag

Date

Today (9)
Last 7 days (20)
Last 30 days (78)
Last 365 days (1468)
2025 (75)
2024 (1467)
2023 (1760)
2022 (2381)
2021 (2405)
2020 (1939)
2019 (1255)
2018 (886)
2017 (1098)
2016 (941)
2015 (1119)
2014 (796)
2013 (659)
2012 (605)
2011 (622)
2010 (529)

Location

Africa (27)
Asia (1303)
Australia (144)
California (214)
Canada (57)
China (16)
Connecticut (9)
Delaware (4)
Europe (5472)
Florida (23)
Illinois (5)
Maryland (75)
Massachusetts (113)
Minnesota (7)
New Jersey (43)
New York (21)
North Carolina (18)
Northern California (79)
Ohio (4)
Pennsylvania (65)
South America (24)
Southern California (79)
Texas (18)
Utah (7)
Washington State (12)

20,858 Results for "oxford biotherapeutics".

Sort By

Press Releases

Boehringer Ingelheim Acquires Fourth License for the Development of Novel Antibody Based Cancer Treatments from Oxford BioTherapeutics

January 9, 2025
·
3 min read
Press Releases

Oxford BioTherapeutics to Present at World ADC Conference 2024

October 31, 2024
·
3 min read
Collaboration

Boehringer Ingelheim Expands Cancer Pipeline With Back-to-Back Antibody Deals

On Thursday, Boehringer Ingelheim announced a partnership with Synaffix to advance antibody-drug conjugates and exercised its fourth license option under a 2013 collaboration with Oxford BioTherapeutics.

January 10, 2025
·
2 min read
·
Tristan Manalac
Oxford BioTherapeutics Announces Launch of Enhanced Discovery Platform, OGAP®-Verify, at World ADC Conference 2024

Oxford BioTherapeutics announces significant technological advances to its drug discovery platform OGAP® with a new version to be launched at the 14th Annual World ADC Conference in London named OGAP®-Verify.

March 7, 2024
·
6 min read
Drug Development

Oxford BioTherapeutics Announces First Patient Dosed with OBT076 in Phase 1b Trial in Adenoid Cystic Carcinomas of the Head and Neck

Oxford BioTherapeutics announces that the first patient has been dosed in a Phase 1b trial investigating OBT’s lead candidate, OBT076, in patients with Adenoid Cystic Carcinoma of the head and neck.

January 18, 2024
·
5 min read
Press Releases

Oxford BioTherapeutics Named Best Tech SME of the Year at Thames Valley Tech & Innovation Awards 2024

July 22, 2024
·
3 min read
Business

Oxford BioTherapeutics Relocates UK Headquarters to Strategic and Cutting-Edge R&D Location at The Oxford Science Park to Accelerate Development of its Immuno-Oncology and ADC-Based Cancer Therapies

Oxford BioTherapeutics Ltd., a clinical stage oncology company with a pipeline of immuno-oncology and antibody-drug conjugate -based therapies, announced that it has relocated its UK headquarters to The Schrodinger Building within The Oxford Science Park.

October 11, 2023
·
3 min read
FDA

Oxford BioTherapeutics Announces Partner Boehringer Ingelheim Received U.S. FDA Fast Track Designation for BI 764532 for the Potential Treatment of Advanced or Metastatic Large-Cell Neuroendocrine Carcinoma of the Lung

Oxford BioTherapeutics today announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BI 764532.

November 29, 2023
·
3 min read
Biotech Bay

Oxford BioTherapeutics to Participate in Panel Discussion at Boehringer Ingelheim’s Upcoming Transforming Science Day: Europe

Oxford BioTherapeutics announces that its Chief Executive Officer, Christian Rohlff, will participate in the panel discussion titled “It takes a village: A holistic approach to external innovation” at Boehringer Ingelheim’s upcoming Transforming Science Day: Europe.

September 19, 2023
·
3 min read
Oxford Nanopore Technologies Collaborates With Twist Bioscience to Launch Pharmacogenomics Beta Programme and Advance Personalised Medicine

Oxford Nanopore Technologies announced the launch of a new Pharmacogenomics Beta Program to advance personalised medicine, combining Twist Bioscience’s next generation sequencing target enrichment technology with Oxford Nanopore’s sequencing platform.

May 22, 2024
·
3 min read

1 of 2,086

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
About
More

© 1985 - 2025 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin